^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

PFI-3

i
Other names: PFI-3
News
Trials
Company:
Pfizer, Structural Genomics Consortium
Drug class:
SMARCA2 inhibitor, SMARCA4 inhibitor
News
Trials